NSE filing, NSE: RAYMOND. Summary written from the filing by ALFA Finder's alert engine.
Raymond Ltd: key numbers
- Share price
- ₹1,105.00
- Market cap
- ₹7,356 Cr
- Revenue (annual)
- ₹2,212 Cr
- Net profit (annual)
- ₹5,341 Cr
- P/E (TTM)
- 153.1×Sector 52.2×
- Promoter holding
- 48.87%+0.00% QoQ
- FII holding
- 7.19%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Raymond Ltd
All →Raymond Earnings Call Transcript: Key Takeaways
Raymond delivers 21% revenue growth driven by a massive 72% jump in Aerospace, though engineering margins remain under pressure from high R&D expensing.
- Call
- Guides 25% growth
Raymond Investor Presentation: Key Takeaways
Q2 FY27 consolidated total income ₹683 Cr (+21%), EBITDA ₹103 Cr (15.1% margin), PAT ₹32 Cr; Aerospace outpaces Precision Tech; net cash surplus ₹77 Cr.
Raymond Results Update
Raymond's Q2 FY27 total income rose 21% to Rs 683 crore, with EBITDA up 30%. The company remains net debt free.
Raymond Q2 FY27 Results: Net Profit ₹32.1 Cr, Up 130.9% YoY
Raymond Ltd reported revenue from operations of ₹655.2 Cr (+24.2% YoY) and net profit of ₹32.1 Cr (+130.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹32.1 Cr · +130.9% YoY
Raymond Other Announcement
Raymond Limited's board approved changing its name to Raymond Aerospace, Defence & Engineering Limited. Shareholder approval, regulatory consents and consequential MOA/AOA amendments are still pending.
Raymond Convertible Warrants
Raymond corrected the EOGM notice details regarding the preferential issue of 33,28,686 warrants to Minerva Ventures Fund, clarifying post-issue shareholding percentages.
Other employee stock options announcements
All →JSW Energy Employee Stock Options
JSW Energy's employee welfare trust transferred 10,044 shares to employees after ESOP option exercises. The off-market transfer was valued at about Rs 0.01 Crore.
- Value
- ₹0.01 Cr
Indegene Employee Stock Options
Indegene Limited allotted 52,194 equity shares under its ESOP schemes, raising paid-up capital to Rs.48.21 Crore. No cash fund raise is involved, so no event value applies.
Alivus Life Sciences Employee Stock Options
Alivus Life Sciences allotted 1,95,833 equity shares to an employee who exercised ESOP options under its 2021 scheme. Paid-up capital rises to Rs. 24.59 Crore.
Archean Chemical Industries Employee Stock Options
Archean Chemical allotted 6,143 equity shares to one grantee under its ESOP 2022 on 29-Oct-2026. Paid-up capital rose to 12,34,64,537 shares.
Intellect Design Arena Employee Stock Options
Intellect Design Arena granted 1,83,500 RSUs to 19 associates under its ISOP/RSU 2016 scheme. This ESOP grant carries no transaction value for the event.
- Execution
- Vesting over 1st to 5th year from grant
Edelweiss Financial Services Employee Stock Options
Edelweiss Financial Services allotted 4,42,792 equity shares under its employee stock incentive and appreciation rights plans. No consideration amount is stated, so no event value applies.